American Radium Society in Kauai, Hawaii on May 2-5, 2015
Absence of Infection from Injection of a Rectal Spacer into the Anterior Peri-Rectal Fat Space presented at the American Radium Society in Kauai, Hawaii on May 2-5, 2015. (Poster of Distinction Award Winner).
Rectal Spacer Injection in Post-Prostatectomy Patients Undergoing High Dose Salvage External Beam Radiation presented at the American Radium Society in Kauai, Hawaii on May 2-5, 2015.
- Combined Modality Radiation Therapy (High Dose Rate Brachytherapy and IMRT) for Treatment of Prostate Cancer: Extensive studies have been performed on the combined modality technique for prostate cancer treatment. Results have proven that HDR (insertion of a temporary radioactive source into prostate) followed by IMRT (radiation therapy delivered from multiple angles around the patient) results in extremely high cure rates over that of IMRT alone. Having a department that is equipped with an outpatient surgical center allows the physician to perform this implant in the same building where the patient will then receive their IMRT, giving the patient a continuity of care that is unfound in any other freestanding radiation therapy center in the country. The newest research study will expand on proven data regarding combination radiation therapy. The study will include almost 500 patients that have been treated over the past 10 years evaluating both prostate cancer control rates for all Gleason score/PSA combinations along with side effects from treatment to better characterize the toxicity profile of the treatment. This research project will involve an ongoing collection of data and will expand as the years pass. Preliminary results are in agreement with those previously published and show that side effects are minimal to non-existent.
- Rectal Spacer Technology: We helped a clinic be on the forefront of the use of spacer material in prostate irradiation. The spacer material allows the rectum to “move” out of harm’s way by injecting a hydrogel into the prostate-rectum interface in order to deliver tumorcidal doses to the prostate for prostate cancer treatment. We have supported, to date, the largest population of patients in the country to utilize this material with amazing results. Patients that may have previously been subjected to rectal irritation or diarrhea as a side effect from treatment are now cruising through treatment with little to no problems. In regards to research on this hydrogel we have helped 10 research posters be accepted to national conferences, two oral presentations given at symposiums and two journal articles published in International Journals. Unfortunately the gel is currently uncovered by insurance and is therefore an out of pocket expense. The Medici Foundation helps support patients that may have otherwise been unable to afford the technology.
- Partial Breast Irradiation: We have also helped support eight studies regarding Partial Breast Irradiation for breast cancer. Local radiation administered at the tumor site is reduced from six weeks of therapy to five days. For the patients that qualify for this modality it is a dramatic reduction in the amount of time spent in treatment with similar cure rates and physical results. The future in breast cancer treatment is in accelerated treatments, meaning that if deemed safe the course of therapy will be decreased while the dose is increased. It is pertinent that we stay on the forefront of this technology.